title: MR appearance of endometrial carcinoma and mucinous cystadenoma in a postmenopausal patient treated with tamoxifen for breast cancer.
abstract: We present a case of endometrial carcinoma accompanied with mucinous cystadenoma in a 70-year-old postmenopausal woman treated with tamoxifen for breast cancer demonstrated by MR imaging. Tamoxifen therapy (20 mg/day) had been carried out for more than 11 years since the surgical procedure for the primary tumor. MR images showed a markedly enlarged uterus containing endometrial carcinoma, cystic atrophy of the endometrium, and a right adnexal mass with multicystic components of various signal intensities.
authors.affiliation: Department of Radiology, Okayama University Medical School, Japan.
authors.forename: I
authors.initials: I
authors.lastname: Joja
authors.forename: T
authors.initials: T
authors.lastname: Asakawa
authors.forename: Y
authors.initials: Y
authors.lastname: Ando
authors.forename: M
authors.initials: M
authors.lastname: Shiraiwa
authors.forename: O
authors.initials: O
authors.lastname: Shibutani
authors.forename: S
authors.initials: S
authors.lastname: Akaki
authors.forename: M
authors.initials: M
authors.lastname: Kuroda
authors.forename: Y
authors.initials: Y
authors.lastname: Mizutani
authors.forename: T
authors.initials: T
authors.lastname: Kudo
authors.forename: Y
authors.initials: Y
authors.lastname: Hiraki
mesh_terms: D000368:Aged; D001943:Breast Neoplasms / Q000188:drug therapy*; D003287:Contrast Media; D018291:Cystadenoma, Mucinous / Q000139:chemically induced* / Q000175:diagnosis; D016889:Endometrial Neoplasms / Q000139:chemically induced* / Q000175:diagnosis; D004717:Endometrium / Q000473:pathology; D004965:Estrogen Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D019786:Gadolinium DTPA; D006801:Humans; D008279:Magnetic Resonance Imaging; D016609:Neoplasms, Second Primary / Q000139:chemically induced* / Q000175:diagnosis; D010051:Ovarian Neoplasms / Q000139:chemically induced* / Q000175:diagnosis; D010053:Ovary / Q000473:pathology; D017698:Postmenopause; D013629:Tamoxifen / Q000009:adverse effects* / Q000627:therapeutic use; D013997:Time Factors
chemical_list: D003287:Contrast Media; D004965:Estrogen Antagonists; D013629:Tamoxifen; C064925:gadodiamide; D019786:Gadolinium DTPA